Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

La Jolla Pharmaceutical Company (LJPC) Trade Now » Rate LJPC - Discuss LJPC - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate LJPC:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

Discuss LJPC

+ Start a new discussion

A FREE report on upcoming FDA decision for small ca.. 1 point Last updated 99 days ago

Posted by

amritadas

N/A

FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opin... ... more »

0 Comment | Related to: LJPC

Free report on upcoming FDA panel decision of Corvu.. 1 point Last updated 105 days ago

Posted by

amritadas

N/A

FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If the drug gets approved by the FDA, it is estimated to achieve Peak sales of $350 million. To read about our ex... ... more »

0 Comment | Related to: LJPC

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+35.23%	368
2	Gerald Greene	18.14	+70.19%	206
3	stockmarketfunding.com	17.66	+25.78%	53
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+69.23%	34

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MO	Altria Group Inc
JPM	JPMorgan Chase & Co
MA	MasterCard Inc
JNJ	Johnson & Johnson
F	Ford Motor Company
NVDA	NVIDIA Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NPD		NPD - CHINA NEPSTAR POISED FOR SIGNIFICANT GROWTH by penny7
EXAS		EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside by Mike Havrilla
DNDN		New Global Equity Index to Track Immunotherapy, Vaccine Stocks by Mike Havrilla
BNI		Railroad Stocks Steam Ahead on Buffett’s Buy of BNI by Mike Havrilla
PALM		Pixi and beyond. by aitebar82

... more »

StreetInsider.com on LJPC

Visit streetinsider.com

More Resources

About La Jolla Pharmaceutical Company - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.